Brazil vs Libya: Cause of death, by non-communicable diseases, ages 5-14, male
Brazil
43.2%
in 2021
Libya
41.6%
in 2021
Brazil rank
67th
Libya rank
70th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Brazil
- Libya
How they compare
Brazil currently reports 43.2% against 41.6% in Libya, a difference of 1.6%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Libya ahead.
Brazil ranks 67th and Libya ranks 70th of 185 countries.
Across the 3 decades both report, Brazil averaged higher in 2 and Libya in 1.
Head to head by decade
| Decade | Brazil | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.3% | 40.2% | 4.9% | Libya |
| 2010s | 39.6% | 29.3% | 10.2% | Brazil |
| 2020s | 42.0% | 36.2% | 5.9% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Brazil or Libya?
- Brazil, at 43.2% against 41.6% in Libya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Brazil and Libya?
- 1.6%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do Brazil and Libya rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Brazil ranks 67th and Libya ranks 70th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.